Global Blood Culture Tests Market Size study & Forecast, by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) and Reg

The Global Blood Culture Tests Market, valued at approximately USD 5.67 billion in 2024, is projected to expand at a robust CAGR of 8.00% from 2025 to 2035. Blood culture testing serves as a cornerstone in clinical diagnostics, enabling the early detection of bloodstream infections, guiding targeted antimicrobial therapy, and ultimately reducing mortality rates associated with sepsis. The increasing prevalence of infectious diseases, growing antibiotic resistance, and the rising global burden of sepsis are collectively driving demand for more sophisticated, rapid, and accurate testing methodologies. Technological advancements—particularly in automated blood culture systems and molecular diagnostics—are enabling laboratories and hospitals to achieve faster turnaround times and higher sensitivity, thereby transforming patient management protocols. Additionally, the steady integration of blood culture testing into routine diagnostic panels across hospitals and reference laboratories is strengthening the market’s growth trajectory.

The market is further buoyed by intensifying efforts from both public health authorities and private players to combat hospital-acquired infections (HAIs) and improve patient outcomes. According to the Centers for Disease Control and Prevention (CDC), sepsis remains one of the leading causes of death in U.S. hospitals, underscoring the clinical urgency for reliable diagnostic tools. The surge in demand for automated systems is not only a response to the need for faster diagnosis but also a consequence of a growing shortage of skilled laboratory personnel, pushing healthcare providers toward high-throughput, less labor-intensive solutions. Simultaneously, the expansion of molecular and proteomics-based approaches is opening up avenues for detecting difficult-to-culture pathogens, which were previously a challenge for traditional culture-based methods. Nevertheless, high equipment costs, limited access to advanced diagnostics in low-resource settings, and the need for standardized protocols present ongoing challenges to market penetration in certain regions.

From a geographical standpoint, North America commands the largest share of the global blood culture tests market, driven by its sophisticated healthcare infrastructure, high awareness levels regarding early diagnosis of sepsis, and significant investments in diagnostic innovation. The United States, in particular, benefits from a strong network of clinical laboratories and high adoption rates of automated testing systems. Europe follows closely, propelled by supportive healthcare policies, stringent infection control regulations, and collaborative research initiatives across member states. Meanwhile, Asia Pacific is anticipated to exhibit the fastest growth over the forecast period, fueled by rising healthcare expenditures, expanding hospital networks, and increased awareness campaigns around infectious disease diagnostics in populous nations like China and India. Emerging markets in Latin America and the Middle East & Africa are also witnessing heightened demand, largely due to improving laboratory capabilities, donor-supported health programs, and the gradual implementation of modern diagnostic technologies.

Major market player included in this report are:
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• bioMérieux SA
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Bruker Corporation
• QIAGEN N.V.
• Cepheid, Inc.
• Ortho Clinical Diagnostics
• Grifols, S.A.
• Hologic, Inc.
• Beckman Coulter, Inc.
• Luminex Corporation

Global Blood Culture Tests Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Method:
• Conventional
• Automated

By Product:
• Consumables
• Instruments

By Technology:
• Culture
• Molecular
• Proteomics

By Application:
• Bacteremia
• Fungemia

By End User:
• Hospitals
• Reference Labs

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe (ROE)

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific (RoAPAC)

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more